Arrakis Therapeutics Company
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Investors
.png)
Founded Date:
2015-01-01
Last Funding Type:
Series B
Headquarters:
Waltham, Massachusetts, United States
Investors Number:
14.0
Technology:
Biopharma, Biotechnology, Medical, Pharmaceutical
Employee Number:
11-50
Industry:
Neurodegenerative disease diagnosis and treatment
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-04-18
Funding Status:
Early Stage Venture
Total Funding:
113000000.0